Latest news with #cardiovascular
Yahoo
6 hours ago
- Business
- Yahoo
Esperion to Report Second Quarter 2025 Financial Results on August 5
ANN ARBOR, Mich., July 22, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced it will report second quarter 2025 financial results before the market opens on Tuesday, August 5, 2025. Following the release, management will host a webcast at 8:00 a.m. ET to discuss these financial results and provide business updates. A live audio webcast can be accessed on the investor and media section of the Esperion website. Access to the webcast replay will be available approximately two hours after completion of the call and will be archived on the Company's website for approximately 90 days. Esperion TherapeuticsEsperion Therapeutics, Inc. is a commercial stage biopharmaceutical company focused on bringing new medicines to market that address unmet needs of patients and healthcare professionals. The Company developed and is commercializing the only U.S. Food and Drug Administration (FDA) approved oral, once-daily, non-statin medicines for patients who are at risk for cardiovascular disease and are struggling with elevated low density lipoprotein cholesterol (LDL-C). These medications are supported by the nearly 14,000 patient CLEAR Cardiovascular Outcomes Trial. Esperion continues to build on its success with its next generation program which is focused on developing ATP citrate lyase inhibitors (ACLYi). New insights into the structure and function of ACLYi fully enables rational drug design and the opportunity to develop highly potent and specific inhibitors with allosteric mechanisms. Esperion continues to evolve into a leading global biopharmaceutical company through commercial execution, international partnerships and collaborations and advancement of its pre-clinical pipeline. For more information, visit and follow Esperion on LinkedIn and X. Esperion Contact Information: Investors: Alina Veneziainvestorrelations@ (734) 887-3903 Media: Tiffany Aldrich corporateteam@ (616) 443-8438Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
6 hours ago
- Health
- Yahoo
NewAmsterdam Pharma to Present Alzheimer's Biomarker Data from BROADWAY Trial at AAIC 2025
– NewAmsterdam to host conference call at 10:00 a.m. ET on Wednesday, July 30th – NAARDEN, the Netherlands and MIAMI, July 22, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or 'NewAmsterdam' or the 'Company'), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (CVD) with elevated low-density lipoprotein cholesterol (LDL-C), for whom existing therapies are not sufficiently effective or well-tolerated, today announced that it will present full data from the prespecified Alzheimer's Disease (AD) biomarker analyses in the BROADWAY clinical trial (NCT05142722) in a late-breaking oral presentation at the Alzheimer's Association International Conference (AAIC), being held July 30, 2025 in Toronto, Canada. Details of the presentation are as follows: Presentation Title: Effects of Obicetrapib, a Potent Oral CETP Inhibitor, on Alzheimer's Disease Biomarkers in 1727 Patients with Cardiovascular DiseaseSession Title: Developing Topics on Innovative Therapeutic ApproachesPresentation Date and Time: Wednesday, July 30, 2025, 8:21-8:28 AM ETPresenter: Philip Scheltens M.D., Room 718 Conference Call and Webcast Information NewAmsterdam will host a live webcast and conference call at 10:00 a.m. ET on July 30, 2025 to review the full AD biomarker data presented at AAIC. The call will include remarks from featured speakers including: Philip Scheltens, M.D., Ph.D., professor of Neurology at the Vrije Universiteit Amsterdam and partner and head of EQT Life Sciences Dementia Fund; Kellyann Niotis, M.D., director of Parkinson's and Lewy Body Dementia Research at The Institute for Neurogenerative Diseases - Parkinson's and Alzheimer's Research Education Foundation; and Nathaniel Chin, M.D., medical director and Clinical Core Co-Leader for the Wisconsin Alzheimer's Disease Research Center (ADRC) and medical director for the Wisconsin Registry for Alzheimer's Prevention (WRAP). To access the live webcast, participants may register here. The live webcast will be available under the 'Events & Presentations' section of the Investor Relations page of the Company's website at To participate via telephone, please register in advance here. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. While not required, it is recommended that participants join the call ten minutes prior to the scheduled start. An archived replay of the webcast will be available on NewAmsterdam's website following the live event. About ObicetrapibObicetrapib is a novel, oral, low-dose CETP inhibitor that NewAmsterdam is developing to overcome the limitations of current LDL-lowering treatments. In each of the Company's Phase 2 trials, ROSE2, TULIP, ROSE, and OCEAN, as well as the Company's Phase 3 BROOKLYN, BROADWAY and TANDEM trials, evaluating obicetrapib as monotherapy or combination therapy, the Company observed statistically significant LDL-lowering combined with a side effect profile similar to that of placebo. The Company commenced the Phase 3 PREVAIL cardiovascular outcomes trial in March 2022, which is designed to assess the potential of obicetrapib to reduce occurrences of MACE. The Company completed enrollment of PREVAIL in April 2024 and randomized over 9,500 patients. Commercialization rights of obicetrapib in Europe, either as a monotherapy or as part of a fixed-dose combination with ezetimibe, have been exclusively granted to the Menarini Group, an Italy-based, leading international pharmaceutical and diagnostics company. About NewAmsterdamNewAmsterdam Pharma (Nasdaq: NAMS) is a late-stage, clinical biopharmaceutical company whose mission is to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. We seek to fill a significant unmet need for a safe, well-tolerated and convenient LDL-lowering therapy. In multiple Phase 3 trials, NewAmsterdam is investigating obicetrapib, an oral, low-dose and once-daily CETP inhibitor, alone or as a fixed-dose combination with ezetimibe, as LDL-C lowering therapies to be used as an adjunct to statin therapy for patients at risk of CVD with elevated LDL-C, for whom existing therapies are not sufficiently effective or well tolerated. Company ContactMatthew PhilippeP: Media ContactReal Chemistry on behalf of NewAmsterdamChristian EdgingtonP: 1-513-310-6410cedgington@ Investor ContactPrecision AQ on behalf of NewAmsterdamAustin MurtaghP: in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
20 hours ago
- Health
- Yahoo
4-Minute Workouts and Other Ways Cardiologists Keep Their Hearts Healthy
IN THE GOOD intentions vs. reality smackdown that is everyday life, reality usually hits you with the low blow. A rough night's sleep. A stressful week at work. One of those months when you dined out more than you worked out. Surprise: All this stuff happens to cardiologists too—and they know how it can lead to weight gain, lost sleep, hardened arteries, and heart disease. But they also know how to pivot. Here are some of their go-to-plan B strategies. The Problem: No Time for the Gym The Fix: Push the Intensity If I can't do a full workout, I go for four to five minutes of high-intensity intervals (30 seconds effort, 30 seconds recovery) on whatever equipment is available, such as a treadmill, stationary bike, rowing machine, or elliptical, plus two sets of compound exercises, like squats or pushups. If I'm away from the gym, I'll do the intervals outside, alternating running with steady jogging. These microworkouts offer many of the same cardiovascular benefits as longer sessions—ideal for busy days. —Jonathan Fisher, MD, Cardiologist and the author of Just One Heart The Problem: Lots to Do, No Time to Eat The Fix: Grab a Better Snack I would rather skip a meal than grab fast food or frozen processed food. You can always get a banana at a gas station. Get two of them. You're much better off eating two bananas on the road than pulling into McDonald's and buying a fish fillet sandwich. Filling, fiber-rich fruit beats overprocessed junk that's high in calories and low in fiber. On a regular day [when I'm not on the road], I snack on dried roasted edamame with wasabi flavor, so it has a little kick to it. Edamame is high in protein and fiber and helps reduce LDL cholesterol. —Joel Kahn, MD, Integrative Cardiologist at The Kahn Center for Cardiac Longevity in Bingham Farms, Michigan The Problem: An Anxiety Pileup The Fix: Book the Chill Thing I receive a relaxing facial once a week. It usually includes a massage with ice globes, and it feels great. Men don't often prioritize things that allow them to meditate or that make them happy. Taking care of your mental health is important, as depression and anxiety are linked with poor cardiovascular health. I also make time to socialize—people tend to underestimate the value of these times because they're always busy working. I prioritize birthdays, weddings, and other valuable time with friends and family. —Yazan Daaboul, Md, Cardiologist and Cardiac Imaging Specialist at Harrison Memorial Hospital The Problem: Morning Fatigue The Fix: Skip the Nightcap I don't recommend drinking before bed. A nightcap with alcohol is a misnomer, since alcohol can increase wakefulness three to four hours later. Additionally, research has shown that there are no heart-healthy effects of alcohol—it's in fact the opposite, so that should not be used as a reason to drink. I like to wind down with a cup of chamomile tea and an audiobook. —Jamal Rana, MD, cardiologist with Kaiser Permanente in Northern California The Problem: Not Sticking to the Plan The Fix: Play the Long Game You don't have to follow every heart health rule perfectly. Rules are meant to be broken. Heart disease doesn't happen due to one unhealthy meal or one day without exercise. The risk increases with unhealthy habits over the long term. Focus on the long game: Just because you make one exception doesn't mean that you can't have a healthy life. —Andrew M. Goldsweig, MD, Director of Cardiovascular Clinical Research at Baystate Medical Center in Springfield, Massachusetts The Problem: Eating Extra The Fix: Don't Starve Yourself I'm a firm believer in the value of the U-turn: If my diet goes off the rails, I make a U-turn and get back to my normal rhythm of eating—generally quick, heart-healthy, vegetable-based meals. If I am too extreme and eat too little, I'm less likely to stick with it. This U-turn mindset has allowed me to lose 25 pounds and keep it off for the past five years. —James Louis Januzzi, MD, Director of the Dennis and Marilyn Barry Fellowship in Cardiology Research at Massachusetts General HospitalThe Problem: Bad Sleep The Fix: Pour Some Coffee The trick for me after a bad night of sleep is coffee. It's actually not harmful for your heart in moderation, which is about two cups a day. I like Starbucks House Blend or Breakfast Blend with 2% milk. It gets me going so I can avoid unhealthy habits and keep up with my exercise—cardio workouts at least three times per week and as much walking throughout the day as possible—regardless of travel, vacations, or work. —Matthew Budoff, MD, endowed chair of Preventive Cardiology at Harbor-UCLA Medical Center Cardiologists Also Recommend This Do the Newer, Better, DIY Heart Check Which is a better way to know if your heart is doing well: a low daily heart rate or a high daily step count? Both, per recent research. Taking them both into account lets you figure out an important number called your heart risk ratio. Here's how to check. 1) Do the Math Daily heart rate / daily step count = heart risk ratio Calculate your average over two weeks. 2) See How you Stack Up You want a ratio below 0.0147. People with this ratio and above had a higher risk of hypertension, heart failure, and coronary atherosclerosis than people below that. So that means, for instance, that someone who walks 10,000 steps a day at an average daily heart rate of 60 has a more efficient heart than someone who walks the same number of steps but at or above a heart rate of 147. Why This Matters 'The coronary arteries supply blood to the heart,' says study author Zhanlin Chen. 'When there are clogs in those arteries, you don't supply as much blood to the heart with every beat, so your heart has to beat more to compensate.' A higher ratio can be a nudge to get more steps in and make other heart-smart moves. You Might Also Like The Best Hair Growth Shampoos for Men to Buy Now 25 Vegetables That Are Surprising Sources of Protein
Globe and Mail
a day ago
- Business
- Globe and Mail
CVRx to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call on August 4, 2025
MINNEAPOLIS, July 21, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that it plans to release second quarter 2025 financial and operating results after market close on Monday, August 4, 2025. The Company will host a conference call to review its results at 4:30pm Eastern Time the same day. A live webcast of the investor conference call will be available online at the investor relations page of the Company's website at To listen to the conference call on your telephone, please dial 1-800-445-7795 for U.S. callers, or 1-785-424-1699 for international callers, approximately ten minutes prior to the start time. Please reference the following conference ID to access the call: CVRXQ225. About CVRx, Inc. CVRx is a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases. Barostim™ is the first medical technology approved by FDA that uses neuromodulation to improve the symptoms of patients with heart failure. Barostim is an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery. The therapy is designed to restore balance to the autonomic nervous system and thereby reduce the symptoms of heart failure. Barostim received the FDA Breakthrough Device designation and is FDA-approved for use in heart failure patients in the U.S. It has been certified as compliant with the EU Medical Device Regulation (MDR) and holds CE Mark for heart failure and resistant hypertension in the European Economic Area. To learn more about Barostim, visit Investor Contact: Mark Klausner or Mike Vallie ICR Westwicke 443-213-0501 ir@ Media Contact: Emily Meyers CVRx, Inc. 763-416-2853 emeyers@
Yahoo
2 days ago
- Health
- Yahoo
What Happens to Your Blood Pressure When You Eat Walnuts Every Day?
What Happens to Your Blood Pressure When You Eat Walnuts Every Day? originally appeared on Parade. If you have hypertension—or are trying to prevent it—the pantry can seem like a minefield. When you want a snack, potato chips, beef jerky and pretzels are all detrimental choices because they are high in sodium, which is a major no-go for managing high blood one food that is a heart-healthy snack? Unsalted nuts. According to cardiovascular dietitians we talked to, walnuts, in particular, are an especially beneficial snack for those with hypertension. 'Walnuts are among the most heart-healthy nuts you can eat,' says cardiovascular dietitian Erin Sheehan, RDN, LND. She explains that the reason why they're such a stand-out nut is due to their high content of alpha-linoleic acid (ALA). 'ALA is a plant-based omega-3 fatty acid known for its anti-inflammatory properties, its ability to lower triglycerides and its support for overall blood vessel health,' she adds. Long story short, eating a handful of walnuts every day can really impact your blood pressure. Keep reading to find out how. 🩺SIGN UP for tips to stay healthy & fit with the top moves, clean eats, health trends & more delivered right to your inbox twice a week💊 Why Are Walnuts Heart-Healthy? Besides containing heart-healthy ALA, Sheehan says that walnuts are also a good source of monounsaturated and polyunsaturated fats, fiber, magnesium and antioxidants, all nutrients that contribute to heart health in their own unique ways. Monounsaturated and polyunsaturated fats are linked to lowering LDL cholesterol. Fiber helps regulate blood sugar, lower cholesterol and maintain a healthy weight. As for magnesium, this nutrient regulates heart muscle contractions, which is important for maintaining a healthy heart rhythm. It also helps control blood pressure. Antioxidants help prevent oxidative stress, which reduces the risk of heart problems. Related: While other nuts are also good for heart health, Lena Beal, MS, RDN, LD, CCTD, a registered dietitian nutritionist and spokesperson for the Academy of Nutrition and Dietetics, agrees that walnuts are one of the most beneficial. 'Walnuts are one of the only tree nuts that provide a significant amount of plant-based omega-3 fatty acids, specifically ALA, which supports a healthy heart by reducing inflammation and improving blood vessel function,' she says. How Does Eating Walnuts Every Day Impact Blood Pressure? Diet plays a huge role in managing blood pressure. If you have hypertension, it's important to be mindful of your entire diet, not just what you snack on. That said, incorporating walnuts into a heart-healthy diet can positively impact blood pressure. 'Eating walnuts regularly can help lower blood pressure by improving flow-mediated dilation, a measure of how well blood vessels expand. Better vessel flexibility and function reduce resistance in the arteries, making it easier for blood to flow and lowering overall blood pressure,' says Michelle Routhenstein, RD, CDE, CND, a cardiovascular dietitian and the owner of Entirely Nourished. Related: ' Beal agrees that regularly eating walnuts can help lower blood pressure. 'Research shows that regular walnut consumption may modestly reduce blood pressure, especially when part of a balanced diet like the DASH or Mediterranean diet. Walnuts promote vasodilation—the widening of blood vessels—which can lead to better blood flow and lower pressure,' she says, echoing Routhenstein. If you want to incorporate walnuts into your diet as a way to help manage blood pressure, Sheehan says that having a small handful of unsalted walnuts most days of the week is enough to make an impact. She says that some ways of incorporating it into your diet include adding them to salads, pairing a handful with dark chocolate, incorporating them into cottage cheese with fruit or sprinkled on walnuts are one of the most heart-healthy nuts there is, all three dietitians say that regularly consuming other unsalted nuts can support blood pressure too. 'Nuts like almonds, pistachios and cashews also offer significant heart health benefits, especially when they replace ultra-processed snack foods,' Sheehan explains. Related: Similar to walnuts, Sheehan says that these nuts provide magnesium, potassium, fiber and unsaturated fats, all of which can help reduce blood pressure and cholesterol levels. 'However, walnuts are unique in their exceptionally high ALA content, giving them a slight edge when it comes to cardiovascular and anti-inflammatory benefits,' she adds. While incorporating unsalted walnuts into your diet is a great way to support blood pressure, all three dietitians say it's important to eat a wide range of nutrient-rich foods; your whole diet matters more than one daily snack. 'Prioritizing a diet rich in fruits, vegetables, whole grains, lean proteins and healthy fats, while minimizing highly processed foods high in saturated fat, sodium and added sugars, is the most sustainable and effective approach for long-term heart health,' Sheehan says. Consider walnuts a small, but mighty piece of the heart-healthy puzzle. Up Next:Sources Erin Sheehan, RDN, LND, cardiovascular dietitian Lena Beal, MS, RDN, LD, CCTD, registered dietitian nutritionist and spokesperson for the Academy of Nutrition and Dietetics Michelle Routhenstein, RD, CDE, CND, cardiovascular dietitian and the owner of Entirely Nourished What Happens to Your Blood Pressure When You Eat Walnuts Every Day? first appeared on Parade on Jul 20, 2025 This story was originally reported by Parade on Jul 20, 2025, where it first appeared.
